Cellular ‘Roadside Assistance’ may prevent harmful TDP-43 aggregates

Impressions
from the
4th FCQC

Martin Wegner awarded
with Alumni Doctoral
Prize for PhD thesis

‘Easy to handle’ Cereblon – a new tool for drug discovery and molecular glue screening

Ivan Đikić Recognized as Highly Cited Researcher for the 7th Consecutive Year

International collaboration discovers role of ubiquitination and ER phagy in combatting defective splicing

IRGQ-mediated autophagy promotes tumor immune evasion

Bhaskara team discovers how intrinsically disordered regions can remodel cellular membranes

Ivan Đikić receives
LOEWE-Spitzenprofessur

Superbugs kill human cells by activating the transcription factors AHR and FOS

4th Frankfurt Conference
on Quality Control
in Life Processes
Registration open!

New insights into
specific roles of
key kinases in ER-phagy

PROXIDRUGS
Cluster4Future
funded for a
further three years

Crosstalk between GPCR
signaling and autophagy
pathways elucidated

Ivan Đikić among Top
Molecular Biology Scientists
2024 Research.com ranking

Funding decision for Collaborative Research Centre “UbiQancer” (CRC/TRR 387)

Alexandra Stolz
appointed as a member of
AIM Rising Stars

Targeted protein degradation
via intramolecular
bivalent glues

Targeting resistant cancers
with new therapeutics

Phosphorylation events on ER-phagy receptors orchestrates ER turnover

Uncovering a
novel checkpoint of
impaired ribosome biogenesis

Christian Münch receives
Lichtenberg-Professorship 

Dies academicus honoring
Pascale Cossart

Successful prolongation
of CRC 1177

Christian Münch
awarded with an
ERC Consolidator Grant

Leukemia cells
activate a cellular
recycling program

Ivan Đikić honored as
Highly Cited Researcher 2023

Honorary doctorate
to Ivan Đikić

Ines Tomaskovic receives DGfA Annual Meeting Award

Lina Herhaus
receives
UCT Conference Award

A cytosolic surveillance mechanism orchestrates mitochondria-to-nucleus communication

Sustainable funding for
excellent basic research

When the cell
digests itself

Alexandra Stolz receives
Exploration Grant from the
Boehringer Ingelheim Foundation

How to regenerate
acutely damaged
lysosomes? 

Ivan Đikić receives
Louis-Jeantet Prize
for Medicine 

Manuel Kaulich
selected as
Henriette Herz Scout

Poster prize
for Anton Altmeyer

Ivan Đikić
appointed as
EMBO Council Member

Poster prizes for
Adriana Covarrubias 
and Alexis González

Drug development collaboration with Karolinska Institute and SciLifeLab 

Third ERC
Advanced Grant
to Ivan Đikić.

Tumor suppressing
mechanism of SUMO
deconjugase SENP6 revealed

Münch group develops
mitochondrial protein
import proteomics

Christian Münch
selected as EMBO
Young Investigator

Ivan Đikić elected to the Academy of Sciences and Literature

Ivan Đikić selected as one of
Highly Cited Researchers 2021

Structure of respiratory complex I resolved at 2.1 Å resolution 

INSA Medal for Dr. Santosh Kumar Kuncha

Otto Meyerhof Award 2021
goes to
Christian Münch

Famotidine inhibits
SARS-CoV-2
signaling

EMBO
Postdoctoral Fellowship
for Santosh Kumar Kuncha

PROXIDRUGS
successful in
Clusters4Future competition

The State of Hesse funds research network on inflammation and infection

Essential role of accessory subunit LYRM6 in the mechanism of mitochondrial complex I.

Scientists call for a Pan-European commitment to reduce SARS-CoV-2 infections

Ivan Đikić honored as
Highly Cited Researcher 2020

Christian Münch wins Binder Innovation Prize 2020.

Host cell signaling responses during SARS-CoV-2 infection reveal therapeutic targets.

Double-hit therapeutic strategy against COVID-19

Expanding a toolkit in chemical screening for discovery of novel medicines.

Uncovering links between SUMO signaling and neurodegenerative disease

Münch group describes potential COVID-19 therapies

Tandem Mass Tag research award for Kevin Klann.

Double-hit therapeutic strategy against COVID-19

“Big Ideas” Essay from Ivan Đikić
_{World Health Day: “Big Ideas” on biomedical challenges.}

Münch group describes coronavirus infection & potential therapies.
_{SARS-CoV-2 infection profile and therapeutic strategies.}

Bremm group reports: Deubiquitinases (DUBs) are regulated by hydroxylation.

mePROD proteomics enables measurement of acute translational changes.